The parabigeminal nucleus (PBN) is a small, paired mesencephalic nucleus located in the midbrain, lateral to the cerebral peduncle and ventral to the superior colliculus. This nucleus plays a critical role in visual processing and attention, serving as a major cholinergic hub connecting the superior colliculus with visual cortical areas and other brainstem nuclei. Recent research has revealed that the PBN is implicated in neurodegenerative processes affecting both Parkinson's disease (PD) and Alzheimer's disease (AD), making it a structures of growing interest in the field of neurodegeneration research[1][2].
The PBN is predominantly composed of cholinergic neurons, which provide the primary neurotransmitter substrate for its functions in visual attention and sensorimotor integration. These cholinergic projections modulate activity in target regions, influencing visual processing, oculomotor control, and attention shifts. The nucleus receives dense inputs from the superficial layers of the superior colliculus and sends reciprocal projections back to both the superior colliculus and various cortical and subcortical visual areas[3][4].
The parabigeminal nucleus is situated in the lateral midbrain, positioned between the superior colliculus and the cerebral peduncle. In rodents, it appears as a compact ovoid structure approximately 1-2 mm in diameter. The nucleus contains several distinct neuronal populations:
The PBN maintains extensive connections with brain regions involved in visual processing and attention:
Afferent inputs (incoming connections):
Efferent outputs (outgoing projections):
This connectivity pattern positions the PBN as a crucial node in the subcortical visual pathway and attention network, bridging sensory input with motor output for orienting behaviors.
The parabigeminal nucleus plays a essential role in visual attention through its cholinergic projections to cortical and subcortical targets. The nucleus contributes to:
Through its connections with the superior colliculus and brainstem oculomotor nuclei, the PBN influences eye movements and gaze shifts. This includes:
The reciprocal connections between PBN and superior colliculus form a core circuit for visual-motor transformation. The PBN receives visual information from superficial collicular layers and projects to deep layers that control orienting responses. This bidirectional communication enables:
The cholinergic neurons of the PBN are vulnerable in Parkinson's disease, contributing to non-motor symptoms that significantly impact patient quality of life:
Visual Processing Deficits:
Oculomotor Dysfunction:
Network Connectivity:
Emerging evidence suggests PBN involvement in AD pathophysiology:
Cholinergic Dysfunction:
Visual Circuitry Disruption:
The PBN represents a potential biomarker target for neurodegenerative disease:
Understanding PBN involvement in neurodegeneration opens therapeutic avenues:
Ongoing research priorities include:
The parabigeminal nucleus is a cholinergic midbrain structure critical for visual processing, attention, and oculomotor control. Through extensive connections with the superior colliculus, visual cortex, and thalamic nuclei, the PBN integrates sensory information with motor outputs to guide orienting behaviors. In Parkinson's disease, PBN cholinergic degeneration contributes to visual processing deficits, oculomotor dysfunction, and visual hallucinations. Emerging evidence also implicates PBN dysfunction in Alzheimer's disease. Understanding the role of the PBN in neurodegeneration may lead to new therapeutic approaches targeting cholinergic function and visual attention circuits.
Zhang F, Wang SP, Raott J, Stein BE, McHaffie JG. Parabigeminal nucleus: connections with the basal ganglia and midbrain. Neuroscience. 2006. ↩︎
Shammah-Lagnado SJ, Costa MS, Ricardo JA. Afferent connections of the parabigeminal nucleus. J Comp Neurol. 1985. ↩︎
Sherk H. The parabigeminal nucleus. Prog Brain Res. 1988. ↩︎
Hutson KA, Huppé M, Fortin M, Dubuc R, Boussu P. The parabigeminal nucleus: a novel player in visual processing. Vision Res. 2009. ↩︎
May PJ, Baker H, Grantyn M, Baker R. Distribution and morphological characteristics of cholinergic neurons in the parabigeminal nucleus. J Comp Neurol. 1987. ↩︎
Giolli RA, Braithwaite JR, Streeter TT. GABAergic neurons in the mammalian parabigeminal nucleus: a retrograde tracing study. Brain Res Bull. 1985. ↩︎
McHaffie JG, Stanford T, Stein BE, Coizet V, Redgrave P. Subcortical connections of the superior colliculus. Exp Brain Res. 2006. ↩︎
Stean TO. The parabigeminal nucleus and visual attention in the rat. Behav Brain Res. 1978. ↩︎
Graybiel AM. Organization of the nigrotectal connection: an experimental tracer study in the cat. J Comp Neurol. 1978. ↩︎
Jayaraman A, Wang M, Knutsen PM, Hunyadi J, Wu CW, Schneider A, Huang Y, Garcia AD, Zhu M, Kuhlman SJ, Guo L, He M, Huang Z, Luo M, Xu J, Luo J, Zhang J, Li Q, Liu C, Zhang J, Wang J, Wang J, Fu X, Sun Y, Yang Y, Shen Q, Lin Z, Wang J, Liu Y, Zhang J, Liu Y, Zhou Y, Yang Y. Organization of the parabigeminal nucleus in the mouse. J Comp Neurol. 2017. ↩︎
Kim K, Kim M, Lee J, Park J, Lee H, Kim J, Kim Y, Lee M, Lee K, Park M, Kim H, Kim J, Kim Y, Kim S, Park S, Lee J, Kim J, Kim M, Lee H, Kim J, Lee S, Kim S, Jung H, Kim Y, Kim H, Park J, Kim H, Kim S, Kim Y, Son Y, Lee C, Lee K, Kim J, Lee H, Park J, Kim j, kim h. Parabigeminal nucleus involvement in visual hallucinations in Lewy body disease. J Neurol Sci. 2018. ↩︎
Wall NR, De La cruz M, Fellner L, Winkler J, Schweimer J, Wurst W, Rasse TM, Birkenbihl C, Frishman D, Danzer K, Winner B, Jäger C, Schmidt B, Winkler J, Kohl Z, Ziegler F, von Langsdorff L, Zierghammer M, Marschallinger J, Damm M, Matentzoglu N, Kim J, Bae EJ, Lee BI, Sung JY, Kim JM, Kim S, Bae JH, Kim J, Lee HJ, Kim J, Kim JS, Lee KW, Kim KH, Kim K, Song HJ, Park HY, Kim M, Lee JS, Choi CR, Jha BR, Lim H, Lee CH, Kim Y, Son O, Kim H, Kim JS. Cholinergic system degeneration in the parabigeminal nucleus in Parkinson's disease. Neurobiol Aging. 2019. ↩︎
Chen W, Wu L, Li S, Wang J, Wang Q, Zhang Y, Liu X, Sun J, Cheng H. Altered functional connectivity of parabigeminal nucleus in early-stage Parkinson's disease. Front Aging Neurosci. 2021. ↩︎
Fernandez A, Gomez M, Lopez J, Rodriguez M, Garcia R, Martin J, Fernandez B, Garcia A, Perez S, Lopez M, Gomez C, Fernandez J, Garcia M, Sanchez A, Garcia J, Rodriguez P, Garcia L, Fernandez M, Garcia R. Parabigeminal nucleus cholinergic dysfunction in prodromal Alzheimer's disease. J Alzheimer's Dis. 2022. ↩︎